1392. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Inhaled ME1100 Dose Selection

1392. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Inhaled ME1100 Dose Selection

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Open forum infectious diseases 2018-11, Vol.5 (suppl_1), p.S427-S428
Hauptverfasser: Bhavnani, Sujata M, Hammel, Jeffrey P, Lakota, Elizabeth A, VanScoy, Brian D, Nagira, Yu, Rubino, Christopher M, Sato, Nobuo, Koresawa, Tomokazu, Kondo, Kenichiro, Ambrose, Paul G
Format: Artikel
Sprache:eng
Schlagworte:
Abstracts
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page S428
container_issue suppl_1
container_start_page S427
container_title Open forum infectious diseases
container_volume 5
creator Bhavnani, Sujata M
Hammel, Jeffrey P
Lakota, Elizabeth A
VanScoy, Brian D
Nagira, Yu
Rubino, Christopher M
Sato, Nobuo
Koresawa, Tomokazu
Kondo, Kenichiro
Ambrose, Paul G
description
doi_str_mv 10.1093/ofid/ofy210.1223
format Article
fullrecord <record><control><sourceid>pubmedcentral_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6252562</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_6252562</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1383-40f13ac746f54e72a05a362f74b6aa84d2191bd04a49a204ec2aa216f1f407053</originalsourceid><addsrcrecordid>eNpVkE1PwzAMhisEEhPszjFHOHTkq18XpGkbMDHEpI1z5KXJFmiTkXRI_fe0GiC42K9t-bX1RNEVwSOCC3brtCm70NK-QSk7iQaU0TzOiyQ7_aPPo2EIbxhjQnCCs2IQfRBW0BFa7sDXIN27saoxMv6py9ZCbSS6Xj7Fy-kNWoPfqgaNmwaMrZXtpIWqDSqgxqHVYb93vkFzu4NKleh51t3BaOqCQitVKdkYZy-jMw1VUMPvfBG93s_Wk8d48fIwn4wXsSQsZzHHmjCQGU91wlVGASfAUqozvkkBcl5SUpBNiTnwAijmSlIASlJNNMcZTthFdHf03R82tSpl96yHSuy9qcG3woER_yfW7MTWfYqUJjRJaWeAjwbSuxC80r-7BIseu-ixiyN20WNnX13Md3A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>1392. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Inhaled ME1100 Dose Selection</title><source>DOAJ Directory of Open Access Journals</source><source>Access via Oxford University Press (Open Access Collection)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Bhavnani, Sujata M ; Hammel, Jeffrey P ; Lakota, Elizabeth A ; VanScoy, Brian D ; Nagira, Yu ; Rubino, Christopher M ; Sato, Nobuo ; Koresawa, Tomokazu ; Kondo, Kenichiro ; Ambrose, Paul G</creator><creatorcontrib>Bhavnani, Sujata M ; Hammel, Jeffrey P ; Lakota, Elizabeth A ; VanScoy, Brian D ; Nagira, Yu ; Rubino, Christopher M ; Sato, Nobuo ; Koresawa, Tomokazu ; Kondo, Kenichiro ; Ambrose, Paul G</creatorcontrib><identifier>ISSN: 2328-8957</identifier><identifier>EISSN: 2328-8957</identifier><identifier>DOI: 10.1093/ofid/ofy210.1223</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><subject>Abstracts</subject><ispartof>Open forum infectious diseases, 2018-11, Vol.5 (suppl_1), p.S427-S428</ispartof><rights>The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252562/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252562/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,865,886,27925,27926,53792,53794</link.rule.ids></links><search><creatorcontrib>Bhavnani, Sujata M</creatorcontrib><creatorcontrib>Hammel, Jeffrey P</creatorcontrib><creatorcontrib>Lakota, Elizabeth A</creatorcontrib><creatorcontrib>VanScoy, Brian D</creatorcontrib><creatorcontrib>Nagira, Yu</creatorcontrib><creatorcontrib>Rubino, Christopher M</creatorcontrib><creatorcontrib>Sato, Nobuo</creatorcontrib><creatorcontrib>Koresawa, Tomokazu</creatorcontrib><creatorcontrib>Kondo, Kenichiro</creatorcontrib><creatorcontrib>Ambrose, Paul G</creatorcontrib><title>1392. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Inhaled ME1100 Dose Selection</title><title>Open forum infectious diseases</title><subject>Abstracts</subject><issn>2328-8957</issn><issn>2328-8957</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNpVkE1PwzAMhisEEhPszjFHOHTkq18XpGkbMDHEpI1z5KXJFmiTkXRI_fe0GiC42K9t-bX1RNEVwSOCC3brtCm70NK-QSk7iQaU0TzOiyQ7_aPPo2EIbxhjQnCCs2IQfRBW0BFa7sDXIN27saoxMv6py9ZCbSS6Xj7Fy-kNWoPfqgaNmwaMrZXtpIWqDSqgxqHVYb93vkFzu4NKleh51t3BaOqCQitVKdkYZy-jMw1VUMPvfBG93s_Wk8d48fIwn4wXsSQsZzHHmjCQGU91wlVGASfAUqozvkkBcl5SUpBNiTnwAijmSlIASlJNNMcZTthFdHf03R82tSpl96yHSuy9qcG3woER_yfW7MTWfYqUJjRJaWeAjwbSuxC80r-7BIseu-ixiyN20WNnX13Md3A</recordid><startdate>20181126</startdate><enddate>20181126</enddate><creator>Bhavnani, Sujata M</creator><creator>Hammel, Jeffrey P</creator><creator>Lakota, Elizabeth A</creator><creator>VanScoy, Brian D</creator><creator>Nagira, Yu</creator><creator>Rubino, Christopher M</creator><creator>Sato, Nobuo</creator><creator>Koresawa, Tomokazu</creator><creator>Kondo, Kenichiro</creator><creator>Ambrose, Paul G</creator><general>Oxford University Press</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20181126</creationdate><title>1392. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Inhaled ME1100 Dose Selection</title><author>Bhavnani, Sujata M ; Hammel, Jeffrey P ; Lakota, Elizabeth A ; VanScoy, Brian D ; Nagira, Yu ; Rubino, Christopher M ; Sato, Nobuo ; Koresawa, Tomokazu ; Kondo, Kenichiro ; Ambrose, Paul G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1383-40f13ac746f54e72a05a362f74b6aa84d2191bd04a49a204ec2aa216f1f407053</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Abstracts</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bhavnani, Sujata M</creatorcontrib><creatorcontrib>Hammel, Jeffrey P</creatorcontrib><creatorcontrib>Lakota, Elizabeth A</creatorcontrib><creatorcontrib>VanScoy, Brian D</creatorcontrib><creatorcontrib>Nagira, Yu</creatorcontrib><creatorcontrib>Rubino, Christopher M</creatorcontrib><creatorcontrib>Sato, Nobuo</creatorcontrib><creatorcontrib>Koresawa, Tomokazu</creatorcontrib><creatorcontrib>Kondo, Kenichiro</creatorcontrib><creatorcontrib>Ambrose, Paul G</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Open forum infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bhavnani, Sujata M</au><au>Hammel, Jeffrey P</au><au>Lakota, Elizabeth A</au><au>VanScoy, Brian D</au><au>Nagira, Yu</au><au>Rubino, Christopher M</au><au>Sato, Nobuo</au><au>Koresawa, Tomokazu</au><au>Kondo, Kenichiro</au><au>Ambrose, Paul G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>1392. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Inhaled ME1100 Dose Selection</atitle><jtitle>Open forum infectious diseases</jtitle><date>2018-11-26</date><risdate>2018</risdate><volume>5</volume><issue>suppl_1</issue><spage>S427</spage><epage>S428</epage><pages>S427-S428</pages><issn>2328-8957</issn><eissn>2328-8957</eissn><cop>US</cop><pub>Oxford University Press</pub><doi>10.1093/ofid/ofy210.1223</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2328-8957
ispartof Open forum infectious diseases, 2018-11, Vol.5 (suppl_1), p.S427-S428
issn 2328-8957
2328-8957
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6252562
source DOAJ Directory of Open Access Journals; Access via Oxford University Press (Open Access Collection); EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Abstracts
title 1392. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Inhaled ME1100 Dose Selection
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T13%3A57%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=1392.%20Pharmacokinetic-Pharmacodynamic%20(PK-PD)%20Target%20Attainment%20Analyses%20to%20Support%20Inhaled%20ME1100%20Dose%20Selection&rft.jtitle=Open%20forum%20infectious%20diseases&rft.au=Bhavnani,%20Sujata%20M&rft.date=2018-11-26&rft.volume=5&rft.issue=suppl_1&rft.spage=S427&rft.epage=S428&rft.pages=S427-S428&rft.issn=2328-8957&rft.eissn=2328-8957&rft_id=info:doi/10.1093/ofid/ofy210.1223&rft_dat=%3Cpubmedcentral_cross%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_6252562%3C/pubmedcentral_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true